{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T17:26:18Z","timestamp":1787073978250,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,21]],"date-time":"2027-07-21T00:00:00Z","timestamp":1816128000000},"content-version":"am","delay-in-days":323,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bbrc.2026.154312","type":"journal-article","created":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T06:24:44Z","timestamp":1784355884000},"page":"154312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Position-dependent effects of loop proline residues on Fab stability and aggregation"],"prefix":"10.1016","volume":"831","author":[{"given":"Ryosei","family":"Kawakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5969-8138","authenticated-orcid":false,"given":"Masato","family":"Kiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitomi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Oda-Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiko","family":"Ishii-Watabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0685-3330","authenticated-orcid":false,"given":"Takatoshi","family":"Ohkuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2026.154312_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s43556-022-00100-4","article-title":"Development of therapeutic antibodies for the treatment of diseases","volume":"3","author":"Wang","year":"2022","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bbrc.2026.154312_bib2","first-page":"233","article-title":"The global landscape of approved antibody therapies","volume":"5","author":"Lyu","year":"2022","journal-title":"Antib. Ther."},{"key":"10.1016\/j.bbrc.2026.154312_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.tibtech.2013.10.002","article-title":"Microbials for the production of monoclonal antibodies and antibody fragments","volume":"32","author":"Spadiut","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbrc.2026.154312_bib4","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/980250","article-title":"scFv antibody: principles and clinical application","volume":"2012","author":"Ahmad","year":"2012","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.bbrc.2026.154312_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0076-6879(89)78036-8","article-title":"Expression of functional antibody Fv and fab fragments in Escherichia coli","volume":"178","author":"Pl\u00fcckthun","year":"1989","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2026.154312_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1042\/bj2810317","article-title":"Expression, purification and characterization of a mouse-human chimeric antibody and chimeric Fab' fragment","volume":"281","author":"King","year":"1992","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2026.154312_bib7","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/ijo.2015.3210","article-title":"Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool","volume":"47","author":"Tsumura","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2026.154312_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.3389\/fphar.2018.01208","article-title":"Targeted intracellular delivery of antibodies: the state of the art","volume":"9","author":"Slastnikova","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bbrc.2026.154312_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41392-021-00868-x","article-title":"Emerging new therapeutic antibody derivatives for cancer treatment","volume":"7","author":"Jin","year":"2022","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2026.154312_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/febs.14991","article-title":"Biophysical characterization and single-chain Fv construction of a neutralizing antibody to measles virus","volume":"287","author":"Tadokoro","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2026.154312_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.jmb.2005.01.053","article-title":"Domain interactions in the Fab fragment: a comparative evaluation of the single-chain Fv and Fab format engineered with variable domains of different stability","volume":"347","author":"R\u00f6thlisberger","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154312_bib12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4161\/mabs.2.2.11271","article-title":"Certolizumab pegol","volume":"2","author":"Goel","year":"2010","journal-title":"MAbs"},{"key":"10.1016\/j.bbrc.2026.154312_bib13","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3389\/fimmu.2017.01287","article-title":"Antibody or antibody fragments: implications for molecular imaging and targeted therapy of solid tumors","volume":"8","author":"Xenaki","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbrc.2026.154312_bib14","doi-asserted-by":"crossref","first-page":"E572","DOI":"10.1208\/aapsj080366","article-title":"Protein aggregation and bioprocessing","volume":"8","author":"Cromwell","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.bbrc.2026.154312_bib15","first-page":"99","article-title":"Immunogenicity of therapeutic proteins: influence of aggregation","volume":"11","author":"Ratanji","year":"2014","journal-title":"J. Immunot."},{"key":"10.1016\/j.bbrc.2026.154312_bib16","doi-asserted-by":"crossref","first-page":"E501","DOI":"10.1208\/aapsj080359","article-title":"Effects of protein aggregates: an immunologic perspective","volume":"8","author":"Rosenberg","year":"2006","journal-title":"AAPS J."},{"key":"10.1016\/j.bbrc.2026.154312_bib17","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/biot.201400052","article-title":"Avoiding antibody aggregation during processing: establishing hold times","volume":"9","author":"Joshi","year":"2014","journal-title":"Biotechnol. J."},{"key":"10.1016\/j.bbrc.2026.154312_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/aic.16814","article-title":"Directed evolution methods for overcoming trade-offs between protein activity and stability","volume":"66","author":"Stimple","year":"2020","journal-title":"AIChE J."},{"key":"10.1016\/j.bbrc.2026.154312_bib19","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1021\/bi026448p","article-title":"Structure-based improvement of the biophysical properties of immunoglobulin VH domains with a generalizable approach","volume":"42","author":"Ewert","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2026.154312_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ymeth.2004.04.007","article-title":"Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering","volume":"34","author":"Ewert","year":"2004","journal-title":"Methods"},{"key":"10.1016\/j.bbrc.2026.154312_bib21","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3389\/fmicb.2020.01927","article-title":"Solubility, stability, and avidity of recombinant antibody fragments expressed in microorganisms","volume":"11","author":"Kang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bbrc.2026.154312_bib22","doi-asserted-by":"crossref","first-page":"22945","DOI":"10.1021\/acsomega.3c01948","article-title":"Molecular dynamics-based design and biophysical evaluation of thermostable single-chain Fv antibody mutants derived from pharmaceutical antibodies","volume":"8","author":"Okazaki","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bbrc.2026.154312_bib23","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jmb.2007.07.061","article-title":"Increasing protein conformational stability by optimizing beta-turn sequence","volume":"373","author":"Trevino","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154312_bib24","doi-asserted-by":"crossref","first-page":"6663","DOI":"10.1073\/pnas.84.19.6663","article-title":"Enhanced protein thermostability from site-directed mutations that decrease the entropy of unfolding","volume":"84","author":"Matthews","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbrc.2026.154312_bib25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/jb\/mvac040","article-title":"Effect of an intermolecular disulfide bond introduced into the first loop of CH1 domain of Adalimumab Fab on thermal stability and antigen-binding activity","volume":"172","author":"Yoshikawa","year":"2022","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154312_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149592","article-title":"Stabilization of adalimumab Fab through the introduction of disulfide bonds between the variable and constant domains","volume":"700","author":"Yoshikawa","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154312_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/jb\/mvad047","article-title":"Analysis of thermostability for seven Phe to Ala and six Pro to Gly mutants in the Fab constant region of adalimumab","volume":"174","author":"Yoshikawa","year":"2023","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154312_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbrc.2017.10.140","article-title":"A novel engineered interchain disulfide bond in the constant region enhances the thermostability of adalimumab Fab","volume":"495","author":"Nakamura","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2026.154312_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/jb\/mvag008","article-title":"Chimeric Fab incorporating the IgM C\u03bc1 domain: insights into physicochemical properties","author":"Sugimoto","year":"2026","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154312_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jb\/mvt061","article-title":"Characterization of deamidation at Asn138 in L-chain of recombinant humanized Fab expressed from Pichia pastoris","volume":"154","author":"Ohkuri","year":"2013","journal-title":"J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154312_bib31","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1021\/acs.jpcb.7b05603","article-title":"Fate of a stressed therapeutic antibody tracked by fluorescence correlation spectroscopy: folded monomers survive aggregation","volume":"121","author":"Imamura","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.bbrc.2026.154312_bib32","first-page":"309","article-title":"The immunoglobulin fold: structural classification, sequence patterns and common core","volume":"242","author":"Bork","year":"1994","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154312_bib33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0006-3495(00)76602-1","article-title":"The thermal stability of immunoglobulin: unfolding and aggregation of a multi-domain protein","volume":"78","author":"Vermeer","year":"2000","journal-title":"Biophys. J."},{"key":"10.1016\/j.bbrc.2026.154312_bib34","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1021\/bi00061a010","article-title":"Effect of proline mutations on the stability and kinetics of folding of staphylococcal nuclease","volume":"32","author":"Nakano","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbrc.2026.154312_bib35","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1080\/19420862.2016.1214785","article-title":"Comparing domain interactions within antibody Fabs with kappa and lambda light chains","volume":"8","author":"Toughiri","year":"2016","journal-title":"MAbs"},{"key":"10.1016\/j.bbrc.2026.154312_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1432-1033.1994.tb20051.x","article-title":"Multiple proline substitutions cumulatively thermostabilize Bacillus cereus ATCC7064 oligo-1,6-glucosidase: irrefragable proof supporting the proline rule","volume":"226","author":"Watanabe","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bbrc.2026.154312_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bej.2023.109139","article-title":"Transition of stability of putidaredoxin reductase by introducing proline","volume":"201","author":"Okamura","year":"2024","journal-title":"Biochem. Eng. J."},{"key":"10.1016\/j.bbrc.2026.154312_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0022-2836(91)90721-H","article-title":"Influence of proline residues on protein conformation","volume":"218","author":"MacArthur","year":"1991","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2026.154312_bib39","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.tibtech.2014.05.005","article-title":"Therapeutic protein aggregation: mechanisms, design, and control","volume":"32","author":"Roberts","year":"2014","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.bbrc.2026.154312_bib40","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1021\/acs.molpharmaceut.4c00077","article-title":"Clues to the design of aggregation-resistant insulin from proline scanning of highly amyloidogenic peptides derived from the N-terminal segment of the A-chain","volume":"21","author":"Pu\u0142awski","year":"2024","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bbrc.2026.154312_bib41","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1021\/acs.biochem.9b01109","article-title":"Analysis of proline substitutions reveals the plasticity and sequence sensitivity of human IAPP amyloidogenicity and toxicity","volume":"59","author":"Ridgway","year":"2020","journal-title":"Biochemistry"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010764?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X26010764?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T16:36:23Z","timestamp":1787070983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X26010764"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":41,"alternative-id":["S0006291X26010764"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154312","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Position-dependent effects of loop proline residues on Fab stability and aggregation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2026.154312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"154312"}}